Parathyroid Klotho and FGF-receptor 1 expression decline with renal function in hyperparathyroid patients with chronic kidney disease and kidney transplant recipients
Related Experiment Video
Updated: Jun 10, 2026

Generation of Hypoparathyroid Rats via Carbon-Nanoparticle-Assisted Parathyroidectomy
Published on: July 14, 2023
Tijana Krajisnik1, Hannes Olauson, Majd A I Mirza
1Department of Medical Sciences, Uppsala University, Uppsala, Sweden. Tijana.Krajisnik@medsci.uu.se
Abstract:
Current studies suggest that short-term exposure of parathyroid glands to fibroblast growth factor 23 (FGF23) reduces parathyroid hormone secretion. However, patients with chronic kidney disease (CKD) develop secondary hyperparathyroidism despite high levels of serum FGF23, indicating a parathyroid FGF23 'resistance'. Here we analyzed the expression of the FGF23 receptors Klotho and FGF receptor 1 (FGFR1) in 88 hyperplastic parathyroid glands from 31 patients with CKD (including 21 renal allograft recipients), and their regulation in isolated bovine and human hyperplastic parathyroid cells. Glandular expression was variable, yet the Klotho and FGFR1 mRNA levels declined in parallel with the decreasing glomerular filtration rate, significantly decreasing over CKD stages. We found no association between the expression of Klotho, FGFR1, and the proliferation marker Ki67. In vitro treatment of bovine cells with FGF23 or calcium reduced the Klotho level, whereas active vitamin D(3) compounds increased its expression. Phosphate and parathyroid hormone had no effect. Treatment had less impact on Klotho in cultured human cells than in the bovine healthy cell model, whereas FGFR1 expression was induced in the hyperplastic cells. Thus parathyroid Klotho and FGFR1 decrease with declining renal function, possibly because of alterations in mineral metabolism related to the failing kidney. This could explain the observed parathyroid resistance to FGF23 in late CKD.
Insights
Parathyroid glands show decreased fibroblast growth factor 23 (FGF23) receptors, Klotho and FGF receptor 1 (FGFR1), with worsening chronic kidney disease (CKD). This FGF23 resistance may explain secondary hyperparathyroidism in CKD patients.
Area of Science:
- Endocrinology
- Nephrology
- Molecular Biology
Background:
- Fibroblast growth factor 23 (FGF23) normally inhibits parathyroid hormone secretion.
- Patients with chronic kidney disease (CKD) paradoxically develop secondary hyperparathyroidism despite elevated FGF23 levels, suggesting FGF23 resistance in parathyroid glands.
Purpose of the Study:
- To investigate the expression and regulation of FGF23 receptors, Klotho and FGF receptor 1 (FGFR1), in parathyroid glands of patients with CKD.
- To explore the potential mechanisms underlying parathyroid FGF23 resistance in CKD.
Main Methods:
- Analysis of Klotho and FGFR1 mRNA expression in 88 hyperplastic parathyroid glands from 31 CKD patients.
- In vitro studies using isolated bovine and human hyperplastic parathyroid cells treated with FGF23, calcium, vitamin D, phosphate, and parathyroid hormone.
Main Results:
- Klotho and FGFR1 mRNA levels in parathyroid glands significantly decreased with declining glomerular filtration rate across CKD stages.
- In vitro, FGF23 and calcium reduced Klotho expression in bovine cells, while vitamin D increased it.
- FGFR1 expression was induced in human hyperplastic cells, and Klotho regulation differed between bovine and human cells.
Conclusions:
- Parathyroid Klotho and FGFR1 expression decline with worsening renal function in CKD.
- Altered mineral metabolism in CKD may contribute to decreased FGF23 receptor expression.
- Reduced parathyroid Klotho and FGFR1 expression likely underlies FGF23 resistance observed in advanced CKD.
Related Concept Videos
The Parathyroid Glands
Oxyphil cells, whose functions remain elusive, emerge during late puberty, adding a layer of complexity to the parathyroid gland's intricacies. In contrast, principal parathyroid cells undertake a vital role by producing...
Chronic Kidney Disease III: Interprofessional Care
Chronic Kidney Disease II: Clinical Manifestations
Kidney Transplant I: Introduction
Chronic Kidney Disease I: Introduction
Roles of Electrolytes: Calcium and Phosphate
The calcium concentration in blood plasma is primarily regulated...

